Antisense Therapeutics Limited

Symbol: ANP.AX

ASX

0.058

AUD

Tržní cena dnes

  • -3.4108

    Poměr P/E

  • -0.0892

    Poměr PEG

  • 52.29M

    MRK Cap

  • 0.00%

    Výnos DIV

Antisense Therapeutics Limited Struktura vedení

Informace o vedení

NázevTitul
Mr. Phillip Allen Hains BBus(Acc), CA, MBAChief Financial Officer & Joint Company Sec.
Dr. Charmaine Gittleson M.D.Executive Chairman
Ms. Nuket DesemDirector of Clinical and Regulatory affairs
Dr. James Garner B.Sc (Hons), B.Sc., M.A., M.A.I.C.D., M.B.A., MBA,Chief Executive Officer, MD & Director
Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A.Chief Financial Officer & Joint Company Secretary
Mr. Mark Diamond B.Sc., M.B.A., BSc, MBA, MAICDChief Executive Officer, MD & Director
Mr. Phillip Allen Hains BBus(Acc), C.A., M.B.A.Chief Financial Officer & Joint Company Sec.
Ms. Alicia MellorsJoint Company Secretary
Ms. Alicia MellorsJoint Company Secretary
Dr. Anthony FilippisChief Operating Officer
Mr. Phillip Allen Hains BBus(Acc), C.A., CA, M.B.A., MBAChief Financial Officer & Joint Company Sec.
Dr. George TachasDirector of Drug Discovery & Patents
Dr. James Garner B.Sc (Hons), B.Sc., M.A., M.A.I.C.D., M.B.A., MBAChief Executive Officer, MD & Director
Dr. Anthony FilippisChief Commercial Officer
Ms. Alicia MellorsJoint Company Sec.